Patrocinado
  • Southeast Asia Molecular Diagnostics Market Set to Surpass $891.87 Million by 2031: Meticulous Research® Unveils Groundbreaking Insights

    Meticulous Research®, a renowned provider of cutting-edge market intelligence solutions, has released an exclusive report titled "Southeast Asia Molecular Diagnostics Market by Offering, Test Type, Technology, Application, End User - Forecast to 2031," shedding light on the burgeoning molecular diagnostics landscape in the region.
    The report forecasts a remarkable surge in the Southeast Asia molecular diagnostics market, projecting a valuation of over $891.87 million by 2031, exhibiting a robust CAGR of 7.8% from 2024 to 2031. Molecular diagnostics, with its ability to detect targeted genetic material in human, viral, and bacterial genomes, is revolutionizing disease diagnosis across various domains including infectious diseases, oncology, and clinical genetics.
    Download Free Sample Report: https://www.meticulousresearch.com/download-sample-report/cp_id=5775
    Driving Forces and Growth Trajectory
    The Southeast Asia molecular diagnostics market is propelled by a multitude of factors, including the burgeoning geriatric population, escalating prevalence of communicable and non-communicable diseases, technological advancements in molecular diagnostics, and increased healthcare expenditures. Moreover, emerging opportunities such as medical tourism in Southeast Asian countries and a growing focus on companion diagnostics are poised to catalyze market expansion. Nonetheless, challenges such as a shortage of skilled professionals and the lack of harmonization of medical device regulations across Southeast Asian countries present hurdles to market growth.
    The report delves into a comprehensive assessment of leading market players' product portfolios, geographic analysis, and key growth strategies implemented over the past three to four years. Notable players profiled in the report include Sansure Biotech, Inc. (China), F. Hoffmann-La Roche Ltd. (Switzerland), Thermo Fisher Scientific Inc. (U.S.), Hologic, Inc. (U.S.), Illumina, Inc. (U.S.), Xiamen Zeesan Biotech Co., Ltd (China), QIAGEN N.V. (Netherlands), Danaher Corporation (U.S.), Abbott Laboratories (U.S.), and Agilent Technologies, Inc. (U.S.).
    Browse in depth @ https://www.meticulousresearch.com/product/south-east-asia-molecular-diagnostics-market-5775
    Elevating the Standard: Companion Diagnostics and Personalized Medicine
    Companion diagnostics (CDx), a cornerstone of personalized, stratified, and precision medicine, are gaining prominence in Southeast Asia. CDx measures levels of proteins, genes, or specific mutations to tailor specific and effective therapies for individual conditions. While adoption of CDx in the region is currently lower compared to developed countries, Southeast Asian countries are gradually embracing CDx. For instance, Malaysian Genomics Resource Centre Bhd (Malaysia) collaborated with ICARTAB Biomedical Co Ltd (iCARTab) (U.S.) and Advanced Immune Therapeutics Sdn Bhd (AIT) (Malaysia) to integrate companion diagnostics and cancer immunotherapy based on Chimeric Antigen Receptor (CAR) T-cells into their portfolio of products and services.

    Segmentation and Market Dynamics
    The Southeast Asia molecular diagnostics market is segmented based on Offering, Test Type, Technology, Application, and End User. Key insights include:
    Offering: The reagents & kits segment is anticipated to lead the market in 2024, driven by recurrent use in disease detection and technological advancements.
    Test Type: Laboratory tests are poised to dominate the market in 2024, owing to their higher accuracy and reliability compared to point-of-care tests.
    Request Free Research Report Sample: https://www.meticulousresearch.com/request-sample-report/cp_id=5775
    Technology: The polymerase chain reaction (PCR) segment is expected to hold the largest market share in 2024, owing to its sensitivity and cost-effectiveness.
    Application: Infectious diseases are projected to command the largest market share in 2024, fueled by rising prevalence and increased funding for diagnostic research.
    End User: Hospitals & clinics are expected to be the key end users in 2024, driven by increased hospitalizations and the high prevalence of healthcare-associated infections.
    Regional Outlook
    Indonesia is poised to emerge as the frontrunner in the Southeast Asia molecular diagnostics market in 2024, fueled by growing adoption, rising prevalence of diseases, and improvements in healthcare infrastructure.
    Quick Buy @ https://www.meticulousresearch.com/Checkout/49985136
    Contact Us:
    Mr. Khushal Bombe
    Meticulous Market Research Inc.
    1267 Willis St, Ste 200 Redding,
    California, 96001, U.S.
    USA: +1-646-781-8004
    Europe : +44-203-868-8738
    APAC: +91 744-7780008
    Email- sales@meticulousresearch.com
    Visit Our Website: https://www.meticulousresearch.com/
    Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
    Southeast Asia Molecular Diagnostics Market Set to Surpass $891.87 Million by 2031: Meticulous Research® Unveils Groundbreaking Insights Meticulous Research®, a renowned provider of cutting-edge market intelligence solutions, has released an exclusive report titled "Southeast Asia Molecular Diagnostics Market by Offering, Test Type, Technology, Application, End User - Forecast to 2031," shedding light on the burgeoning molecular diagnostics landscape in the region. The report forecasts a remarkable surge in the Southeast Asia molecular diagnostics market, projecting a valuation of over $891.87 million by 2031, exhibiting a robust CAGR of 7.8% from 2024 to 2031. Molecular diagnostics, with its ability to detect targeted genetic material in human, viral, and bacterial genomes, is revolutionizing disease diagnosis across various domains including infectious diseases, oncology, and clinical genetics. Download Free Sample Report: https://www.meticulousresearch.com/download-sample-report/cp_id=5775 Driving Forces and Growth Trajectory The Southeast Asia molecular diagnostics market is propelled by a multitude of factors, including the burgeoning geriatric population, escalating prevalence of communicable and non-communicable diseases, technological advancements in molecular diagnostics, and increased healthcare expenditures. Moreover, emerging opportunities such as medical tourism in Southeast Asian countries and a growing focus on companion diagnostics are poised to catalyze market expansion. Nonetheless, challenges such as a shortage of skilled professionals and the lack of harmonization of medical device regulations across Southeast Asian countries present hurdles to market growth. The report delves into a comprehensive assessment of leading market players' product portfolios, geographic analysis, and key growth strategies implemented over the past three to four years. Notable players profiled in the report include Sansure Biotech, Inc. (China), F. Hoffmann-La Roche Ltd. (Switzerland), Thermo Fisher Scientific Inc. (U.S.), Hologic, Inc. (U.S.), Illumina, Inc. (U.S.), Xiamen Zeesan Biotech Co., Ltd (China), QIAGEN N.V. (Netherlands), Danaher Corporation (U.S.), Abbott Laboratories (U.S.), and Agilent Technologies, Inc. (U.S.). Browse in depth @ https://www.meticulousresearch.com/product/south-east-asia-molecular-diagnostics-market-5775 Elevating the Standard: Companion Diagnostics and Personalized Medicine Companion diagnostics (CDx), a cornerstone of personalized, stratified, and precision medicine, are gaining prominence in Southeast Asia. CDx measures levels of proteins, genes, or specific mutations to tailor specific and effective therapies for individual conditions. While adoption of CDx in the region is currently lower compared to developed countries, Southeast Asian countries are gradually embracing CDx. For instance, Malaysian Genomics Resource Centre Bhd (Malaysia) collaborated with ICARTAB Biomedical Co Ltd (iCARTab) (U.S.) and Advanced Immune Therapeutics Sdn Bhd (AIT) (Malaysia) to integrate companion diagnostics and cancer immunotherapy based on Chimeric Antigen Receptor (CAR) T-cells into their portfolio of products and services. Segmentation and Market Dynamics The Southeast Asia molecular diagnostics market is segmented based on Offering, Test Type, Technology, Application, and End User. Key insights include: Offering: The reagents & kits segment is anticipated to lead the market in 2024, driven by recurrent use in disease detection and technological advancements. Test Type: Laboratory tests are poised to dominate the market in 2024, owing to their higher accuracy and reliability compared to point-of-care tests. Request Free Research Report Sample: https://www.meticulousresearch.com/request-sample-report/cp_id=5775 Technology: The polymerase chain reaction (PCR) segment is expected to hold the largest market share in 2024, owing to its sensitivity and cost-effectiveness. Application: Infectious diseases are projected to command the largest market share in 2024, fueled by rising prevalence and increased funding for diagnostic research. End User: Hospitals & clinics are expected to be the key end users in 2024, driven by increased hospitalizations and the high prevalence of healthcare-associated infections. Regional Outlook Indonesia is poised to emerge as the frontrunner in the Southeast Asia molecular diagnostics market in 2024, fueled by growing adoption, rising prevalence of diseases, and improvements in healthcare infrastructure. Quick Buy @ https://www.meticulousresearch.com/Checkout/49985136 Contact Us: Mr. Khushal Bombe Meticulous Market Research Inc. 1267 Willis St, Ste 200 Redding, California, 96001, U.S. USA: +1-646-781-8004 Europe : +44-203-868-8738 APAC: +91 744-7780008 Email- sales@meticulousresearch.com Visit Our Website: https://www.meticulousresearch.com/ Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
    0 Comentários 0 Compartilhamentos 606 Visualizações 0 Anterior
  • Revolutionize your IT landscape with our expert advice! Dive into our guide tailored for CIOs, exploring the steps to modernize monolithic applications for a more agile and innovative organization. Don't get left behind in the digital race! #CIOInsights #ModernizationStrategy #AgileTech

    Source: https://www.valuecoders.com/blog/app-development/modernizing-monolithic-apps-guide-for-cios/
    Revolutionize your IT landscape with our expert advice! Dive into our guide tailored for CIOs, exploring the steps to modernize monolithic applications for a more agile and innovative organization. Don't get left behind in the digital race! #CIOInsights #ModernizationStrategy #AgileTech Source: https://www.valuecoders.com/blog/app-development/modernizing-monolithic-apps-guide-for-cios/
    WWW.VALUECODERS.COM
    Modernizing Monolithic Apps – Guide for CIOs
    Expert strategies for modernizing monolithic applications. Get actionable insights for successful app modernization initiatives, ideal for CIOs.
    0 Comentários 0 Compartilhamentos 100 Visualizações 0 Anterior
  • Renowned for his strategic foresight, Jeremy Johnson Temecula consistently delivers results by aligning his decision-making with the long-term vision of the business. His proactive approach to problem-solving and innovation ensures that the organization remains agile and resilient in the face of change. Click here - https://www.quora.com/profile/Jeremy-Johnson-Murrieta
    Renowned for his strategic foresight, Jeremy Johnson Temecula consistently delivers results by aligning his decision-making with the long-term vision of the business. His proactive approach to problem-solving and innovation ensures that the organization remains agile and resilient in the face of change. Click here - https://www.quora.com/profile/Jeremy-Johnson-Murrieta
    WWW.QUORA.COM
    Jeremy Johnson Murrieta
    Following 38 people. Wrote 14 answers.
    0 Comentários 0 Compartilhamentos 77 Visualizações 0 Anterior
  • MVP Development Company

    We help you build a Minimum Viable Product – a minimalist version with core features – to test the waters before diving in. This agile approach lets you gather real user feedback, improvise quickly, and ensure your product truly resonates with your target market.

    Read More: https://www.narolainfotech.com/custom/mvp-development/

    #mvp #mvpdevelopemnt #mvpdevelopemntcomapny #mvpsoftware #mvpsoftwaredevelopment #mvpdevelopmentservices
    MVP Development Company We help you build a Minimum Viable Product – a minimalist version with core features – to test the waters before diving in. This agile approach lets you gather real user feedback, improvise quickly, and ensure your product truly resonates with your target market. Read More: https://www.narolainfotech.com/custom/mvp-development/ #mvp #mvpdevelopemnt #mvpdevelopemntcomapny #mvpsoftware #mvpsoftwaredevelopment #mvpdevelopmentservices
    WWW.NAROLAINFOTECH.COM
    MVP Development
    MVP development company with 18+ years of expertise offering MVP software development services for startups, web and app with core functionalities based on real-time market insights.
    0 Comentários 0 Compartilhamentos 436 Visualizações 0 Anterior
  • Looking to take your offshore software development to the next level? Dive into our blog post on scaling Agile for valuable insights and strategies. Elevate your team's performance today!
    https://www.sphinx-solution.com/blog/how-to-scale-agile-in-offshore-software-development/
    #AgileScaling #SoftwareDevelopment #Innovation
    Looking to take your offshore software development to the next level? Dive into our blog post on scaling Agile for valuable insights and strategies. Elevate your team's performance today! https://www.sphinx-solution.com/blog/how-to-scale-agile-in-offshore-software-development/ #AgileScaling #SoftwareDevelopment #Innovation
    WWW.SPHINX-SOLUTION.COM
    How to Scale Agile in Offshore Software Development
    Do you think your project is subjected to add frequent small changes? If yes! then, Agile is the best option for you to implement changes at very low cost.
    0 Comentários 0 Compartilhamentos 246 Visualizações 0 Anterior
  • Benefits Of Agile Software Development For Business In 2024!

    Unlock business agility with 2024's top benefits of Agile software development! Stay competitive, adapt quickly, and boost innovation with Agile practices.

    Read More:- https://www.worldwebtechnology.com/blog/benefits-of-agile-software-development-for-business/

    #agilesoftware #softwaredevelopment #softwaredevelopmentcompany #softwaredevelopmentlifecycle #softwaredevelopmentprocess #worldwebtechnology
    Benefits Of Agile Software Development For Business In 2024! Unlock business agility with 2024's top benefits of Agile software development! Stay competitive, adapt quickly, and boost innovation with Agile practices. Read More:- https://www.worldwebtechnology.com/blog/benefits-of-agile-software-development-for-business/ #agilesoftware #softwaredevelopment #softwaredevelopmentcompany #softwaredevelopmentlifecycle #softwaredevelopmentprocess #worldwebtechnology
    0 Comentários 0 Compartilhamentos 486 Visualizações 0 Anterior
  • Cloud Consulting Services

    Cloud fuels impactful transformations, enabling agile innovations in models, experiences, and products. Discover Xoriant’s Cloud Infrastructure services, where we build, operate, and drive scalability on the cloud, simplifying complexities. Thrive on a cloud-forward strategy with us!

    https://www.xoriant.com/cloud-infrastructure-services
    Cloud Consulting Services Cloud fuels impactful transformations, enabling agile innovations in models, experiences, and products. Discover Xoriant’s Cloud Infrastructure services, where we build, operate, and drive scalability on the cloud, simplifying complexities. Thrive on a cloud-forward strategy with us! https://www.xoriant.com/cloud-infrastructure-services
    Xoriant Cloud & Infrastructure: Move, Modernize, Thrive on Cloud.
    Discover Xoriant's Cloud & Infrastructure services, where we build, operate, and drive scalability on the cloud, simplifying complexities. Thrive on a cloud-forward strategy with us!
    0 Comentários 0 Compartilhamentos 315 Visualizações 0 Anterior
  • North America Molecular Diagnostics Market to be Worth $18.13 Billion by 2030
    North America Molecular Diagnostics Market by Product (Reagents & Kits, Systems, Software), Test Type (Lab, PoC), Technology (PCR, ISH, INAAT, Sequencing, Microarray), Application (Infectious Diseases, Oncology, Neurological), End User - Forecast to 2030
    ________________________________________
    Meticulous Research®, a leading global market research company, published a research report titled, ‘North America Molecular Diagnostics Market by Product (Reagents & Kits, Systems, Software), Test Type (Lab, PoC), Technology (PCR, ISH, INAAT, Sequencing, Microarray), Application (Infectious Diseases, Oncology, Neurological), End User—Forecast to 2030.’
    According to this latest publication from Meticulous Research®, the North America molecular diagnostics market is expected to reach $18.13 billion by 2030 at a CAGR of 5.3% from 2023 to 2030. The growth of the North America molecular diagnostics market is driven by several factors, including the rising geriatric population, the increasing prevalence of communicable & non-communicable diseases, technological advancements in molecular diagnostics, and rising healthcare expenditures. However, unfavorable regulatory frameworks and the high costs of molecular diagnostic tests restrain the growth of this market.
    Key Players
    The key players operating in the North America molecular diagnostics market are Hologic, Inc. (U.S.), Danaher Corporation (U.S.), BioMérieux S.A. (France), Becton, Dickinson and Company (U.S.), Siemens Healthineers AG (Germany), DiaSorin S.p.A. (Italy), Abbott Laboratories (U.S.), Thermo Fisher Scientific Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Illumina, Inc. (U.S.), F. Hoffmann-La Roche (Switzerland), QIAGEN N.V. (Netherlands), and Seegene, Inc. (South Korea).
    North America Molecular Diagnostics Market: Future Outlook
    Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5642

    Have Any Query? Ask To Analyst:
    https://www.meticulousresearch.com/speak-to-analyst/cp_id=5642
    Geographic Review
    Quick Buy: https://www.meticulousresearch.com/Checkout/41114062
    Key questions answered in the report-
    • Which are the high-growth market segments in terms of product & service, test type, technology, application, end user, and geography?
    • What was the historical market for molecular diagnostics across North America?
    • What are the market forecasts and estimates for the period 2023–2030?
    • What are the major drivers, restraints, opportunities, and challenges in the North America molecular diagnostics market?
    • Who are the major players in the North America molecular diagnostics market?
    • What is the competitive landscape, and who are the market leaders in the North America molecular diagnostics market?
    Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5642

    Contact Us:
    Meticulous Research®
    Email- sales@meticulousresearch.com
    Contact Sales- +1-646-781-8004
    Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

    North America Molecular Diagnostics Market to be Worth $18.13 Billion by 2030 North America Molecular Diagnostics Market by Product (Reagents & Kits, Systems, Software), Test Type (Lab, PoC), Technology (PCR, ISH, INAAT, Sequencing, Microarray), Application (Infectious Diseases, Oncology, Neurological), End User - Forecast to 2030 ________________________________________ Meticulous Research®, a leading global market research company, published a research report titled, ‘North America Molecular Diagnostics Market by Product (Reagents & Kits, Systems, Software), Test Type (Lab, PoC), Technology (PCR, ISH, INAAT, Sequencing, Microarray), Application (Infectious Diseases, Oncology, Neurological), End User—Forecast to 2030.’ According to this latest publication from Meticulous Research®, the North America molecular diagnostics market is expected to reach $18.13 billion by 2030 at a CAGR of 5.3% from 2023 to 2030. The growth of the North America molecular diagnostics market is driven by several factors, including the rising geriatric population, the increasing prevalence of communicable & non-communicable diseases, technological advancements in molecular diagnostics, and rising healthcare expenditures. However, unfavorable regulatory frameworks and the high costs of molecular diagnostic tests restrain the growth of this market. Key Players The key players operating in the North America molecular diagnostics market are Hologic, Inc. (U.S.), Danaher Corporation (U.S.), BioMérieux S.A. (France), Becton, Dickinson and Company (U.S.), Siemens Healthineers AG (Germany), DiaSorin S.p.A. (Italy), Abbott Laboratories (U.S.), Thermo Fisher Scientific Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Illumina, Inc. (U.S.), F. Hoffmann-La Roche (Switzerland), QIAGEN N.V. (Netherlands), and Seegene, Inc. (South Korea). North America Molecular Diagnostics Market: Future Outlook Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5642 Have Any Query? Ask To Analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5642 Geographic Review Quick Buy: https://www.meticulousresearch.com/Checkout/41114062 Key questions answered in the report- • Which are the high-growth market segments in terms of product & service, test type, technology, application, end user, and geography? • What was the historical market for molecular diagnostics across North America? • What are the market forecasts and estimates for the period 2023–2030? • What are the major drivers, restraints, opportunities, and challenges in the North America molecular diagnostics market? • Who are the major players in the North America molecular diagnostics market? • What is the competitive landscape, and who are the market leaders in the North America molecular diagnostics market? Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5642 Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
    0 Comentários 0 Compartilhamentos 1313 Visualizações 0 Anterior
  • Asia-Pacific In Vitro Diagnostics Market on Track to Reach $36.02 Billion by 2031
    ‘Asia-Pacific In Vitro Diagnostics Market by Offering (Kits, Software), Technology (Immunoassay, Molecular Diagnostics [PCR, NGS, Microarray], Rapid Tests, Biochemistry), Application (Infectious Diseases, Oncology), Diagnostic Approach - Forecast to 2031.’
    According to this latest publication from Meticulous Research®, the Asia-Pacific In Vitro Diagnostics (IVD) market is expected to reach $36.02 billion by 2031 at a CAGR of 7% from 2024 to 2031. The growth of the Asia-Pacific IVD market is attributed to the rising prevalence of chronic and infectious diseases, the growing demand for point-of-care (PoC) and rapid diagnostics, rising awareness regarding early disease diagnosis, rising healthcare expenditures, and increasing funding for research activities. However, stringent technical requirements and regulatory processes for high/moderate-complexity tests and the variance in test results observed in rapid IVD tests restrain the growth of the IVD market. The increasing inclination toward personalized medicine and advancements in genomics and proteomics are expected to create growth opportunities for the players operating in this market. However, the concerns pertaining to false positive results in immunoassays and POC are a major challenge for market growth.
    Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5750

    Key Players
    The key players operating in the Asia-Pacific IVD market are Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), Sysmex Corporation (Japan), bioMérieux SA (France), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Seegene Inc. (South Korea), Illumina, Inc. (U.S.), Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China), Siemens Healthineers AG (Germany), Thermo Fisher Scientific Inc. (U.S.), QuidelOrtho Corporation (U.S.), and Agilent Technologies Inc. (U.S.).
    Asia-Pacific IVD Market: Future Outlook
    𝐇𝐚𝐯𝐞 𝐚𝐧𝐲 𝐪𝐮𝐞𝐫𝐲 𝐀𝐒𝐊 𝐄𝐗𝐏𝐄𝐑𝐓 :
    https://www.meticulousresearch.com/speak-to-analyst/cp_id=5750
    by Offering
    • Kits & Reagents
    • Instruments
    • Software & Services
    by Technology
    • Molecular Diagnostics
    o Polymerase Chain Reaction (PCR)
    o Hybridization
    o Isothermal Nucleic Acid Amplification Technology
    o DNA Sequencing & Next-generation Sequencing
    o Microarrays
    o Mass Spectrometry
    o Other Molecular Diagnostic Technologies
    • Point of Care (PoC) Diagnostics
    o Lateral Flow Assays/Rapid Tests
    o POC Molecular Diagnostics
    o Other PoC Products
    • Immunoassay/Immunochemistry
    o Enzyme-linked Immunosorbent Assays (ELISA)
    o Radioimmunoassays
    o Western Blotting
    o Enzyme-Linked Immunospot Assays
    o Immunohistochemistry (IHC)
    • Biochemistry/Clinical Chemistry
    o Metabolic Panel
    o Electrolyte Panel
    o Liver Panel
    o Lipid Profile
    o Renal Profile
    o Thyroid Function Panel
    • Whole Blood Glucose Monitoring
    • Microbiology
    • Hematology
    • Coagulation/Hemostasis
    • Urinalysis
    • Other IVD Technologies
    by Application
    • Infectious Diseases
    o COVID-19 Testing
    o Sexually Transmitted Diseases (STD) Testing
    o Healthcare-associated Infections (HAIs)
    o Hepatitis
    o HIV
    o Tropical Diseases
    o Respiratory Infections (Excluding Influenza)
    o Influenza
    o Other Infectious Diseases
    • Oncology
    • Diabetes
    • Cardiology
    • Nephrology
    • Autoimmune Disorders
    • Other Applications
    by Diagnostic Approach
    • Lab Testing
    • OTC/Self-testing
    • Point of Care Testing
    by End User
    • Diagnostic Laboratories
    • Hospitals & Clinics
    • Home Healthcare
    • Other End Users
    by Country/Region
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Thailand
    • Singapore
    • Indonesia
    • Rest of Asia-Pacific
    Browse Here:
    https://www.meticulousresearch.com/product/asia-pacific-in-vitro-diagnostics-market-5750
    Key questions answered in the report:
    • Which are the high-growth market segments in terms of offering, technology, application, diagnostic approach, end user, and country?
    • What was the historical market for IVD testing in Asia-Pacific?
    • What are the market forecasts and estimates for the period 2024–2031?
    • What are the major drivers, restraints, challenges, and opportunities in the Asia-Pacific IVD market?
    • Who are the major players in the Asia-Pacific IVD market?
    Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5750

    ContactUs:
    MeticulousResearch®
    Email- sales@meticulousresearch.com
    ContactSales-+1-646-781-8004
    Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

    Asia-Pacific In Vitro Diagnostics Market on Track to Reach $36.02 Billion by 2031 ‘Asia-Pacific In Vitro Diagnostics Market by Offering (Kits, Software), Technology (Immunoassay, Molecular Diagnostics [PCR, NGS, Microarray], Rapid Tests, Biochemistry), Application (Infectious Diseases, Oncology), Diagnostic Approach - Forecast to 2031.’ According to this latest publication from Meticulous Research®, the Asia-Pacific In Vitro Diagnostics (IVD) market is expected to reach $36.02 billion by 2031 at a CAGR of 7% from 2024 to 2031. The growth of the Asia-Pacific IVD market is attributed to the rising prevalence of chronic and infectious diseases, the growing demand for point-of-care (PoC) and rapid diagnostics, rising awareness regarding early disease diagnosis, rising healthcare expenditures, and increasing funding for research activities. However, stringent technical requirements and regulatory processes for high/moderate-complexity tests and the variance in test results observed in rapid IVD tests restrain the growth of the IVD market. The increasing inclination toward personalized medicine and advancements in genomics and proteomics are expected to create growth opportunities for the players operating in this market. However, the concerns pertaining to false positive results in immunoassays and POC are a major challenge for market growth. Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5750 Key Players The key players operating in the Asia-Pacific IVD market are Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), Sysmex Corporation (Japan), bioMérieux SA (France), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Seegene Inc. (South Korea), Illumina, Inc. (U.S.), Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China), Siemens Healthineers AG (Germany), Thermo Fisher Scientific Inc. (U.S.), QuidelOrtho Corporation (U.S.), and Agilent Technologies Inc. (U.S.). Asia-Pacific IVD Market: Future Outlook 𝐇𝐚𝐯𝐞 𝐚𝐧𝐲 𝐪𝐮𝐞𝐫𝐲 𝐀𝐒𝐊 𝐄𝐗𝐏𝐄𝐑𝐓 : https://www.meticulousresearch.com/speak-to-analyst/cp_id=5750 by Offering • Kits & Reagents • Instruments • Software & Services by Technology • Molecular Diagnostics o Polymerase Chain Reaction (PCR) o Hybridization o Isothermal Nucleic Acid Amplification Technology o DNA Sequencing & Next-generation Sequencing o Microarrays o Mass Spectrometry o Other Molecular Diagnostic Technologies • Point of Care (PoC) Diagnostics o Lateral Flow Assays/Rapid Tests o POC Molecular Diagnostics o Other PoC Products • Immunoassay/Immunochemistry o Enzyme-linked Immunosorbent Assays (ELISA) o Radioimmunoassays o Western Blotting o Enzyme-Linked Immunospot Assays o Immunohistochemistry (IHC) • Biochemistry/Clinical Chemistry o Metabolic Panel o Electrolyte Panel o Liver Panel o Lipid Profile o Renal Profile o Thyroid Function Panel • Whole Blood Glucose Monitoring • Microbiology • Hematology • Coagulation/Hemostasis • Urinalysis • Other IVD Technologies by Application • Infectious Diseases o COVID-19 Testing o Sexually Transmitted Diseases (STD) Testing o Healthcare-associated Infections (HAIs) o Hepatitis o HIV o Tropical Diseases o Respiratory Infections (Excluding Influenza) o Influenza o Other Infectious Diseases • Oncology • Diabetes • Cardiology • Nephrology • Autoimmune Disorders • Other Applications by Diagnostic Approach • Lab Testing • OTC/Self-testing • Point of Care Testing by End User • Diagnostic Laboratories • Hospitals & Clinics • Home Healthcare • Other End Users by Country/Region • China • Japan • India • Australia • South Korea • Thailand • Singapore • Indonesia • Rest of Asia-Pacific Browse Here: https://www.meticulousresearch.com/product/asia-pacific-in-vitro-diagnostics-market-5750 Key questions answered in the report: • Which are the high-growth market segments in terms of offering, technology, application, diagnostic approach, end user, and country? • What was the historical market for IVD testing in Asia-Pacific? • What are the market forecasts and estimates for the period 2024–2031? • What are the major drivers, restraints, challenges, and opportunities in the Asia-Pacific IVD market? • Who are the major players in the Asia-Pacific IVD market? Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5750 ContactUs: MeticulousResearch® Email- sales@meticulousresearch.com ContactSales-+1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
    0 Comentários 0 Compartilhamentos 2244 Visualizações 0 Anterior
  • Unlock innovation and efficiency with dedicated agile teams for your startup! Discover the transformative power of collaboration and adaptability. Elevate your development game. #AgileDevelopment #Startups #DedicatedTeams #TechRevolution

    Source: https://www.valuecoders.com/blog/on-demand-teams/why-startups-choose-dedicated-teams-for-agile-development/






    Unlock innovation and efficiency with dedicated agile teams for your startup! Discover the transformative power of collaboration and adaptability. Elevate your development game. #AgileDevelopment #Startups #DedicatedTeams #TechRevolution Source: https://www.valuecoders.com/blog/on-demand-teams/why-startups-choose-dedicated-teams-for-agile-development/
    WWW.VALUECODERS.COM
    Why Startups Should Choose Dedicated Teams for Agile Development?
    Explore power of dedicated agile teams for startups. Elevate efficiency, flexibility, and innovation. Accelerate success with right development approach!
    0 Comentários 0 Compartilhamentos 400 Visualizações 0 Anterior
Páginas Impulsionadas
Patrocinado

Instant Money Transfers - Open Free Account

Mobile Money made easy, all currencies

Patrocinado